University of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental therapy
for advanced childhood leukemia that is expected to become the first CAR T - cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy
for HIV
Cure at Fred Hutchinson
Cancer Research Center.